ArticleClinical Medicine Insights. Oncology2022

Whole-Brain Radiotherapy Combined With Anlotinib for Multiple Brain Metastases From Non-small Cell Lung Cancer Without Targetable Driver Mutation: A Single-Arm, Phase II Study.

Jianjiang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.